Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05830552
Other study ID # PNUHH-2109-021-107
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 1, 2021
Est. completion date April 30, 2022

Study information

Verified date April 2023
Source Pusan National University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The Effect of Feedback on Physical Activity Surveillance using Wearable Device-Smartphone Application for Resolution of Metabolic Syndrome in Aged 60 or older; a 12-Week Randomized Control Study


Description:

Research on whether wearable device interventions can effectively prevent metabolic syndrome remains insufficient. This study aimed to evaluate the effect of feedback on clinical indicators in patients with metabolic syndrome aged 60 or older on activities measured using wearable devices, such as smartphone apps. Patients aged 60 or older diagnosed with metabolic syndrome were recruited and prescribed to survive for 12 weeks using wrist-worn devices (B.BAND, B Life Inc, Korea). The block randomization method was used to distribute the participants between an intervention group (n=20) and control group (n=20). In the intervention group, an experienced study coordinator provided feedback on physical activity to individuals through telephone counseling every other week.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date April 30, 2022
Est. primary completion date April 30, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 60 Years to 99 Years
Eligibility Inclusion Criteria: - Diagnosed with metabolic syndrome by a doctor. - Aged 60 or older. - A person who understands the clinical trial process and signs the consent form - Possession of a smartphone and a daily mobile phone user for the past 3. months and expected to use for more than 3 months. - A person who agrees to provide the data on the amount of physical activity measured and collected by a wearable device. - A person who can exercise at an intensity more than walking for 12 weeks. Exclusion Criteria: - Under the aged 60. - A person who does not agree to provide data on physical activity. - Those who who are judged to have difficulty in exercising such as walking due to uncontrolled diabetes, high blood pressure or serious cardiovascular disease. - A person who is not used to or is reluctant to use a smartphone app. - Those who have difficulty wearing wearable devices due to skin diseases around their wrists. - A person who is expected to have an unintended change in weight over the next three months due to current pregnancy and planning, thyroid disease, cancer, etc.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Receving feedback
Receving regular feedback from a health provider
No regular feedback
No regular feedback from a health provider

Locations

Country Name City State
Korea, Republic of Pusan National University Hospital Busan Seo-gu

Sponsors (1)

Lead Sponsor Collaborator
Pusan National University Hospital

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Other Gathering subject information from the survey All participants received information on demographics, occupation (usually for estimating physical activity intensity), frequency and duration of physical activity, history (diagnosis or drug treatment of hypertension, diabetes or dyslipidemia), health-related habits (smoking, drinking and alcohol), and medications taken through the survey. Participants were defined as non-smokers, past smokers, and current smokers, and non-smokers (0 to 98 g/week) or drinkers who drink an average of 7 cups of men and 5 or more cups of women twice per person. Baseline
Primary Changes in fasting blood tests at baseline and 12th week visits Blood samples were collected from the Jeonju vein after fasting for 6 hours and analyzed in our hospital's laboratory. The lipid profile was tested using an automated analyzer (Hitachi 747, Hitachi Corp, Japan) and enzyme colorimetric method. Baseline and 12th week
Primary Changes in blood pressure (systolic blood pressure, diastolic blood pressure) at baseline and 12th week visits Blood pressure was measured in a sitting position after resting using BP-203 RVII(Colin Corp, Aichi, Japan). Baseline and 12th week
Primary Changes in waist circumference (cm) at baseline and 12th week visits The waist circumference was evaluated by a trained examiner (after normal exhalation) to the nearest millimeter from the midpoint between the lower edge of the rib and the iliac ridge. Baseline and 12th week
Primary Measurement of physical activity through wearable devices Investigators provided with wrist-wearable device (B.BAND, B Life Inc, Korea), which allowed them to wear and live for 12 weeks. Researchers who have been granted access can check and track participants' physical activity on a daily basis through a web page. For 12 weeks
Secondary Changes in body weight at baseline and 12th week visits Body weight in kilograms were measured using a digital scale and stadiometer (BSM370, Biospace Co Ltd, Seoul). Baseline and 12th week
Secondary Changes in height at baseline and 12th week visits Height in meters were measured using a digital scale and stadiometer (BSM370, Biospace Co Ltd, Seoul). Baseline and 12th week
Secondary Changes in body composition at baseline and 12th week visits Body composition was measured by bioelectrical impedance analysis (Inbody 720, Biospace Co Ltd, Seoul) Baseline and 12th week
Secondary Depression index at baseline and 12th week visits All participants completed the Beck Depression Inventory (BDI) questionnaires. Baseline and 12th week
Secondary Stress scale questionnaires at baseline and 12th week visits All participants completed the Perceived Stress Scale (PSS) questionnaires. Baseline and 12th week
Secondary Pulse wave velocity measurement on baseline and 12th week visits Pulse wave velocity was measured in a comfortable supine position using the VP-1000 plus (Omron Healthcare, Bannockburn, IL). Baseline and 12th week
See also
  Status Clinical Trial Phase
Recruiting NCT04635202 - Effect of Elliptical Training on Metabolic Homeostasis in Metabolic Syndrome N/A
Completed NCT05343858 - Pilot Study to Evaluate the Effect of Two Microalgae Consumption on Metabolic Syndrome N/A
Completed NCT04053686 - An Intervention to Reduce Prolonged Sitting in Police Staff N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Recruiting NCT05040958 - Carotid Atherosclerotic Plaque Load and Neck Circumference
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Active, not recruiting NCT02500147 - Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS) Phase 4
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Completed NCT03289897 - Non-invasive Rapid Assessment of NAFLD Using Magnetic Resonance Imaging With LiverMultiScan N/A
Recruiting NCT05956886 - Sleep Chatbot Intervention for Emerging Black/African American Adults N/A
Completed NCT06057896 - Effects of Combined Natural Molecules on Metabolic Syndrome in Menopausal Women
Active, not recruiting NCT03613740 - Effect of Fucoxanthin on the Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion Phase 2
Completed NCT04498455 - Study of a Prebiotic Supplement to Mitigate Excessive Weight Gain Among Physicians in Residency Phase 4
Completed NCT05688917 - Green Coffee Effect on Metabolic Syndrome N/A
Completed NCT04117802 - Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome N/A
Completed NCT03697382 - Effect of Daily Steps on Fat Metabolism N/A
Completed NCT03241121 - Study of Eating Patterns With a Smartphone App and the Effects of Time Restricted Feeding in the Metabolic Syndrome N/A
Completed NCT04509206 - Virtual Teaching Kitchen N/A
Completed NCT05124847 - TREating Pediatric Obesity N/A